Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz
Leticee, N.; Viard, J.-P.; Yamgnane, A.; Karmochkine, M.; Benachi, A.
Contraception 85(4): 425-427
2012
ISSN/ISBN: 1879-0518 PMID: 22036046 DOI: 10.1016/j.contraception.2011.09.005Document Number: 223695
Contraception for HIV-positive women is a complex issue. Although the use of condoms is recommended, complementary methods of contraception are often prescribed. Antiretroviral therapy can lead to drug interactions and modify the efficacy of hormonal contraception. Two unintended pregnancies suggest that etonogestrel implants should be used with caution in patients on efavirenz.
Document emailed within 0-6 h
Related Documents
Vieira, C.S.; Bahamondes, M.V.; de Souza, R.M.; Brito, M.B.; Rocha Prandini, T.R.; Amaral, E.; Bahamondes, L.; Duarte, G.; Quintana, S.M.; Scaranari, C.; Ferriani, R.A. 2014: Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women Journal of Acquired Immune Deficiency Syndromes 66(4): 378-385Linet, T.; Levy Bachelot, L.; Farge, G.; Crespi, S.; Yang, J.; Robert, J.; Fabron, C. 2020: PIH7 Cost-Effectiveness Analysis of Etonogestrel Contraceptive Implant Compared to SIX other Contraceptive Methods Based on Real Life DATA in France Value in Health 23: S539-S540
Linet, T.; Levy Bachelot, L.; Farge, G.; Crespi, S.; Yang, J.; Robert, J.; Fabron, C. 2020: PIH7 Cost-Effectiveness Analysis of Etonogestrel Contraceptive Implant Compared to SIX other Contraceptive Methods Based on Real Life DATA in France Value in Health 23: S539-S540
Mornar, S.; Chan, L.-N.; Mistretta, S.; Neustadt, A.; Martins, S.; Gilliam, M. 2012: Pharmacokinetics of the etonogestrel contraceptive implant in obese women American Journal of Obstetrics and Gynecology 207(2): 110.E1-6
Lartigau-Roussin, C.; Receveur, M.C.; Roussin, J.M.; Bouffart, S.; Abaine, A. 2006: The subcutaneous etonogestrel implant: a new contraceptive method in Mayotte? Bulletin de la Societe de Pathologie Exotique 99(1): 11-14
Morrell, K.M.; Cremers, S.; Westhoff, C.L.; Davis, A.R. 2016: Relationship between etonogestrel level and BMI in women using the contraceptive implant for more than 1 year Contraception 93(3): 263-265
Biskamp, C.; Kauffman, R.P. 2016: Arm flexion during ultrasound assists localization of an intramuscular etonogestrel contraceptive implant Contraception 93(3): 273-275
Sonalkar, S.; Hou, M.Y.; Hou, M.; Borgatta, L. 2013: Administration of the etonogestrel contraceptive implant on the day of mifepristone for medical abortion: a pilot study Contraception 88(5): 671-673
Bryant, A.G.; Bauer, A.E.; Stuart, G.S.; Levi, E.E.; Zerden, M.L.; Danvers, A.; Garrett, J.M. 2017: Etonogestrel-Releasing Contraceptive Implant for Postpartum Adolescents: a Randomized Controlled Trial Journal of Pediatric and Adolescent Gynecology 30(3): 389-394
Lazorwitz, A.; Aquilante, C.L.; Oreschak, K.; Sheeder, J.; Guiahi, M.; Teal, S. 2019: Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users Obstetrics and Gynecology 133(4): 783-794
Modesto, W.; Dal Ava, N.ál.; Monteiro, I.; Bahamondes, L. 2015: Body composition and bone mineral density in users of the etonogestrel-releasing contraceptive implant Archives of Gynecology and Obstetrics 292(6): 1387-1391
Caruso, S.; Vitale, S.Giovanni.; Fava, V.; Pasqua, S.Di.; Rapisarda, A.Maria.Chiara.; Cianci, S. 2020: Quality of life of women using the etonogestrel long-acting reversible contraceptive implant after abortion for unplanned pregnancy European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 25(4): 251-258
Iwanaga, J.; Fox, M.C.; Rekers, H.; Schwartz, L.; Tubbs, R.S. 2019: Neurovascular anatomy of the adult female medial arm in relationship to potential sites for insertion of the etonogestrel contraceptive implant Contraception 100(1): 26-30
Scarsi, K.; Lamorde, M.; Darin, K.; Penchala, S.D.; Else, L.; Nakalema, S.; Byakika-Kibwika, P.; Khoo, S.; Cohn, S.; Merry, C.; Back, D. 2014: Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant Journal of the International Aids Society 17(4 Suppl 3: 19484
Di Carlo, C.; Sansone, A.; De Rosa, N.; Gargano, V.; Tommaselli, G.A.; Nappi, C.; Bifulco, G. 2014: Impact of an implantable steroid contraceptive (etonogestrel-releasing implant) on quality of life and sexual function: a preliminary study Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 30(1): 53-56
Lafuma, A.; Agostini, A.; Linet, T.; Robert, J.; Levy-Bachelot, L.; Godard, C. 2015: Cost-Effectiveness of Nexplanon® (Etonogestrel Implant) Compared to other Reimbursed Contraceptive Methods in France Based on Real Life Data Value in Health 18(7): A735-A736
Landolt, N.K.; Phanuphak, N.; Ubolyam, S.; Pinyakorn, S.; Kerr, S.; Ahluwalia, J.; Thongpaeng, P.; Thammajaruk, N.; Cremers, S.; Thomas, T.; Chaithongwongwatthana, S.; Lange, J.M.A.; Ananworanich, J. 2014: Significant decrease of ethinylestradiol with nevirapine, and of etonogestrel with efavirenz in HIV-positive women Journal of Acquired Immune Deficiency Syndromes 66(2): E50-E52
Mariana, N.; Purwantyastuti; Instiaty; Rusli, A. 2016: Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin Acta Medica Indonesiana 48(1): 10-16
Casey, P.M.; Long, M.E.; Drozdowicz, L.B.; Marnach, M.L.; Weaver, A.L. 2014: Management of etonogestrel subdermal implant-related bleeding Journal of Reproductive Medicine 59(5-6): 306-312
Barros Pereira, I.; Carvalho, R.M.; Graça, L.ís.M. 2015: Intra-abortion contraception with etonogestrel subdermal implant European Journal of Obstetrics Gynecology and Reproductive Biology 185: 33-35